303 related articles for article (PubMed ID: 17869638)
1. Vasoactive intestinal peptide inhibits liver pathology in acute murine schistosomiasis mansoni and modulates IL-10, IL-12 and TNF-alpha production.
Allam G
Immunobiology; 2007; 212(8):603-12. PubMed ID: 17869638
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni.
Allam G
Immunobiology; 2009; 214(8):712-27. PubMed ID: 19249123
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor plays a role in Schistosoma mansoni egg-induced granulomatous inflammation.
Joseph AL; Boros DL
J Immunol; 1993 Nov; 151(10):5461-71. PubMed ID: 8228238
[TBL] [Abstract][Full Text] [Related]
4. Modulation of T lymphocyte proliferation in mice infected with Schistosoma mansoni: VIP suppresses mitogen- and antigen-induced T cell proliferation possibly by inhibiting IL-2 production.
Metwali A; Blum A; Mathew R; Sandor M; Lynch RG; Weinstock JV
Cell Immunol; 1993 Jun; 149(1):11-23. PubMed ID: 8099848
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma, IL-12, and TNF-alpha are required to maintain reduced liver pathology in mice vaccinated with Schistosoma mansoni eggs and IL-12.
Hoffmann KF; Caspar P; Cheever AW; Wynn TA
J Immunol; 1998 Oct; 161(8):4201-10. PubMed ID: 9780194
[TBL] [Abstract][Full Text] [Related]
6. Toxoplasma gondii and Schistosoma mansoni synergize to promote hepatocyte dysfunction associated with high levels of plasma TNF-alpha and early death in C57BL/6 mice.
Marshall AJ; Brunet LR; van Gessel Y; Alcaraz A; Bliss SK; Pearce EJ; Denkers EY
J Immunol; 1999 Aug; 163(4):2089-97. PubMed ID: 10438948
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection.
Mathew RC; Cook GA; Blum AM; Metwali A; Felman R; Weinstock JV
J Immunol; 1992 Jun; 148(11):3572-7. PubMed ID: 1588046
[TBL] [Abstract][Full Text] [Related]
8. Clinico-pathological effects of Schistosoma mansoni infection associated with simultaneous exposure to malathion in Swiss outbred albino mice.
Elsheikha HM; Hussein HS; Rahbar MH
Acta Trop; 2008 Oct; 108(1):11-9. PubMed ID: 18722991
[TBL] [Abstract][Full Text] [Related]
9. Immunization with rP22 induces protective immunity against Schistosoma mansoni: effects on granuloma down-modulation and cytokine production.
Rezende CM; Silva MR; Santos IG; Silva GA; Gomes DA; Goes AM
Immunol Lett; 2011 Dec; 141(1):123-33. PubMed ID: 21945176
[TBL] [Abstract][Full Text] [Related]
10. IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease.
Wynn TA; Cheever AW; Williams ME; Hieny S; Caspar P; Kühn R; Müller W; Sher A
J Immunol; 1998 May; 160(9):4473-80. PubMed ID: 9574553
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and the Th2 response combine to prevent severe hepatic damage during Schistosoma mansoni infection.
Brunet LR; Beall M; Dunne DW; Pearce EJ
J Immunol; 1999 Nov; 163(9):4976-84. PubMed ID: 10528202
[TBL] [Abstract][Full Text] [Related]
12. Serum cytokines of the 20 Krad-irradiated S. mansoni cercariae vaccinated, primary and superinfected Cercopethicus aethiops aethiops.
Torben W; Hailu A
Exp Parasitol; 2007 Feb; 115(2):121-6. PubMed ID: 16949577
[TBL] [Abstract][Full Text] [Related]
13. The hepatoprotective activity of blue green algae in Schistosoma mansoni infected mice.
Mohamed AH; Osman GY; Salem TA; Elmalawany AM
Exp Parasitol; 2014 Oct; 145():7-13. PubMed ID: 25016189
[TBL] [Abstract][Full Text] [Related]
14. Differential immunoregulation of granulomatous inflammation, portal hypertension, and hepatic fibrosis in murine schistosomiasis mansoni.
Olds GR; el Meneza S; Mahmoud AF; Kresina TF
J Immunol; 1989 May; 142(10):3605-11. PubMed ID: 2497177
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni: relationship of tumor necrosis factor-alpha to morbidity and collagen deposition in chronic experimental infection.
Adewusi OI; Nix NA; Lu X; Colley DG; Secor WE
Exp Parasitol; 1996 Nov; 84(2):115-23. PubMed ID: 8932761
[TBL] [Abstract][Full Text] [Related]
16. Effect of combined chemotherapy and anti-inflammatory drugs on murine schistosomiasis.
Mahmoud MR; Zoheiry MM; Nosseir MM
Arzneimittelforschung; 2002; 52(4):294-301. PubMed ID: 12040972
[TBL] [Abstract][Full Text] [Related]
17. Effects of pentoxifylline during Schistosoma mansoni infection in Swiss mice: an analysis of worm burden, fecundity and liver histopathology.
Mati VL; Freitas RM; Melo AL
J Helminthol; 2010 Dec; 84(4):348-54. PubMed ID: 20109246
[TBL] [Abstract][Full Text] [Related]
18. VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
Kojima M; Ito T; Oono T; Hisano T; Igarashi H; Arita Y; Kawabe K; Coy DH; Jensen RT; Nawata H
Pancreas; 2005 Jan; 30(1):62-70. PubMed ID: 15632701
[TBL] [Abstract][Full Text] [Related]
19. Schistosoma mansoni: effect of dietary zinc supplement on egg granuloma in Swiss mice treated with praziqantel.
Helmy MM; Mahmoud SS; Fahmy ZH
Exp Parasitol; 2009 Aug; 122(4):310-7. PubMed ID: 19389399
[TBL] [Abstract][Full Text] [Related]
20. IL-4 inhibits vasoactive intestinal peptide production by macrophages.
Metwali A; Blum AM; Elliott DE; Weinstock JV
Am J Physiol Gastrointest Liver Physiol; 2002 Jul; 283(1):G115-21. PubMed ID: 12065298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
